Generation of autochthonous mouse models of clear cell renal cell carcinoma: mouse models of renal cell carcinoma

Kidney cancer: developing useful mouse models Genetically engineered mouse models allow more detailed understanding of kidney cancers, say researchers in China. Current treatments for clear cell renal cell carcinoma (ccRCC), a common form of kidney cancer, are limited, and mouse models can help by r...

Full description

Bibliographic Details
Main Authors: Weibin Hou, Zhigang Ji
Format: Article
Language:English
Published: Nature Publishing Group 2018-04-01
Series:Experimental and Molecular Medicine
Online Access:https://doi.org/10.1038/s12276-018-0059-4
id doaj-6688f246a719463a9110974c022fbe85
record_format Article
spelling doaj-6688f246a719463a9110974c022fbe852020-12-08T13:50:49ZengNature Publishing GroupExperimental and Molecular Medicine2092-64132018-04-0150411010.1038/s12276-018-0059-4Generation of autochthonous mouse models of clear cell renal cell carcinoma: mouse models of renal cell carcinomaWeibin Hou0Zhigang Ji1Department of Urology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical CollegeDepartment of Urology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical CollegeKidney cancer: developing useful mouse models Genetically engineered mouse models allow more detailed understanding of kidney cancers, say researchers in China. Current treatments for clear cell renal cell carcinoma (ccRCC), a common form of kidney cancer, are limited, and mouse models can help by revealing how tumors are initiated and progress. Zhigang Ji and Weibin Hou at the Peking Union Medical College Hospital in Beijing reviewed recent progress in ccRCC mouse models. In contrast to the longtime stagnation of only being able to produce ccRCC-like cell structures and cystic lesions, researchers recently have successfully produced true ccRCCs in mice by deactivating tumor suppressor genes, overexpressing oncogenic genes, or enhancing signaling pathways, in various combinations. Hou and Ji suggest that these exciting ccRCC mouse models could be especially useful for the investigation of the emerging immunotherapy for ccRCC.https://doi.org/10.1038/s12276-018-0059-4
collection DOAJ
language English
format Article
sources DOAJ
author Weibin Hou
Zhigang Ji
spellingShingle Weibin Hou
Zhigang Ji
Generation of autochthonous mouse models of clear cell renal cell carcinoma: mouse models of renal cell carcinoma
Experimental and Molecular Medicine
author_facet Weibin Hou
Zhigang Ji
author_sort Weibin Hou
title Generation of autochthonous mouse models of clear cell renal cell carcinoma: mouse models of renal cell carcinoma
title_short Generation of autochthonous mouse models of clear cell renal cell carcinoma: mouse models of renal cell carcinoma
title_full Generation of autochthonous mouse models of clear cell renal cell carcinoma: mouse models of renal cell carcinoma
title_fullStr Generation of autochthonous mouse models of clear cell renal cell carcinoma: mouse models of renal cell carcinoma
title_full_unstemmed Generation of autochthonous mouse models of clear cell renal cell carcinoma: mouse models of renal cell carcinoma
title_sort generation of autochthonous mouse models of clear cell renal cell carcinoma: mouse models of renal cell carcinoma
publisher Nature Publishing Group
series Experimental and Molecular Medicine
issn 2092-6413
publishDate 2018-04-01
description Kidney cancer: developing useful mouse models Genetically engineered mouse models allow more detailed understanding of kidney cancers, say researchers in China. Current treatments for clear cell renal cell carcinoma (ccRCC), a common form of kidney cancer, are limited, and mouse models can help by revealing how tumors are initiated and progress. Zhigang Ji and Weibin Hou at the Peking Union Medical College Hospital in Beijing reviewed recent progress in ccRCC mouse models. In contrast to the longtime stagnation of only being able to produce ccRCC-like cell structures and cystic lesions, researchers recently have successfully produced true ccRCCs in mice by deactivating tumor suppressor genes, overexpressing oncogenic genes, or enhancing signaling pathways, in various combinations. Hou and Ji suggest that these exciting ccRCC mouse models could be especially useful for the investigation of the emerging immunotherapy for ccRCC.
url https://doi.org/10.1038/s12276-018-0059-4
work_keys_str_mv AT weibinhou generationofautochthonousmousemodelsofclearcellrenalcellcarcinomamousemodelsofrenalcellcarcinoma
AT zhigangji generationofautochthonousmousemodelsofclearcellrenalcellcarcinomamousemodelsofrenalcellcarcinoma
_version_ 1724389189734105088